SC 13D

Company

TENAX THERAPEUTICS, INC.

Filed

June 22, 2021

Accession Number

0001654954-21-007128

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →